EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer

Michael Bau Mortensen

Status: Unknown

Conditions: Esophageal Cancer; Stomach Cancer; Pancreatic Cancer

Treatments: Procedure: PET/CT and EUS; Behavioral: standard follow-up

Study type: Interventional

Funder types: Other

Identifiers

NCT02209415

2011-41-5702

Details and patient eligibility

About

Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic.

This is because the methods and the consequence of following these patients is unknown.

Therefore the investigators will randomize these patients in to two groups:

1. One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department.
2. The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.

Enrollment: 182 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• R0- resection for primary adenocarcinoma or squamous cell carcinoma of the esophagus, stomach or pancreas.

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

182 participants in 2 patient groups

Standard outpatient follow-up

Active Comparator group

Description:

Outpatient clinic visits 3,6,9,12,18 and 24 mths after surgery

Treatment:

Behavioral: standard follow-up

Intervention PET/CT and EUS

Experimental group

Description:

PET/CT and EUS at 3,6,9,12,18 and 24 months after surgery

Treatment:

Procedure: PET/CT and EUS